{
  "docId": "019de071-fee7-744f-89ad-50de02e7ef2c",
  "docSlug": "b5a336d0fe4b7b554c90c4664e01c224",
  "documentTitle": "Comera | SPAC Presentation Deck | 33 slides",
  "authorId": "comera",
  "authorName": "Comera Life Sciences",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2022-01-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 18,
  "pageCount": 33,
  "prevPage": 17,
  "nextPage": 19,
  "slideType": "solution",
  "function": "present_solution",
  "density": "dense",
  "nDataPoints": 24,
  "notes": "The slide uses a 'Target viscosity range' shaded area to visually emphasize the efficacy of the caffeine-based excipient.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de071-fee7-744f-89ad-50de02e7ef2c/18",
  "deckHref": "/decks/019de071-fee7-744f-89ad-50de02e7ef2c",
  "deckJsonHref": "/decks/019de071-fee7-744f-89ad-50de02e7ef2c.json",
  "deckAnchorHref": "/decks/019de071-fee7-744f-89ad-50de02e7ef2c#slide-18",
  "components": [
    {
      "bbox": {
        "h": 0.5,
        "w": 0.4,
        "x": 0.55,
        "y": 0.25
      },
      "kind": "chart",
      "text": "Viscosity vs Ipilimumab concentration",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a65f7c0a-75f8-4034-a3a5-ec80d4ea4aa5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.4,
        "x": 0.05,
        "y": 0.25
      },
      "kind": "chart",
      "text": "Viscosity vs Infliximab concentration",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c8f44b97-243b-4224-be10-242f4cd4ca63",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.4,
        "x": 0.05,
        "y": 0.8
      },
      "kind": "paragraph",
      "text": "Infliximab formulated in a 20 mM phosphate-acetate buffer at pH 6.0 (control) and in the presence of 75 mM caffeine, 100 mM ArgHCl, or 100 mM NaCl",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "13f7d796-8ba8-48ee-b7a1-c05c5191df99",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.4,
        "x": 0.55,
        "y": 0.8
      },
      "kind": "paragraph",
      "text": "Ipilimumab formulated in Yervoy commercial formulation vehicle (Comm.) and PBS with or without 75 mM caffeine",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "52e1fa35-8fb9-4b8a-af4c-9fd58b6fa962",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.7,
        "x": 0.04,
        "y": 0.94
      },
      "kind": "source-note",
      "text": "Source: “Caffeine as a viscosity reducer for highly concentrated monoclonal antibody solutions” Journal of Pharmaceutical Sciences 110 (2021) 3594–3604",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bfb4ed35-6858-4fa8-9999-68eea507f150",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.75,
        "x": 0.04,
        "y": 0.04
      },
      "kind": "title",
      "text": "Caffeine-based Excipient is Optimized Viscosity-Lowering Beneficial SQore™ Excipient for Several Biologics",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fa40f3b1-69df-43da-8d87-a81d02aad125",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Chart Selection Guide",
      "slug": "chart-selection-guide",
      "agent": "Designer",
      "layer": "slide",
      "matchId": "04aea1b7-cc17-4076-83a4-55296826842c",
      "evidence": "chart/line: Viscosity vs Infliximab concentration, chart/line: Viscosity vs Ipilimumab concentration",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 18,
      "from": 16,
      "beatId": "f7fcc03e-4c20-4453-81c4-2a8923e2db08",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Solution",
      "beatSlug": "sequoia-pitch-solution",
      "evidence": "The deck presents Comera's proprietary excipient technology platform, SQore, as a solution to the problem.",
      "position": 1,
      "confidence": 0.9,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}